Keyphrases
Multiple Sclerosis
100%
Interferon-α (IFN-α)
100%
T Helper 17 (Th17)
100%
Experimental Autoimmune Encephalomyelitis
62%
Central Nervous System
50%
Th17 Lymphocytes
50%
Multiple Sclerosis Treatment
37%
Lymphocytes
37%
Interleukin-17 (IL-17)
37%
Blood-brain Barrier
25%
Interleukin-23 (IL-23)
25%
Relapsing-remitting multiple Sclerosis
25%
Endothelial Cells
12%
Transcription Factor
12%
Healthy Controls
12%
T Cells
12%
Brain Tissue
12%
In Situ
12%
Substantial Evidence
12%
T Helper 1
12%
In Vivo Evidence
12%
Primary Culture
12%
Human Memory
12%
Inflammatory Events
12%
Model Experimental
12%
T-bet
12%
Effector Phase
12%
Memory Lymphocyte
12%
Immune Cell Migration
12%
Medicine and Dentistry
Multiple Sclerosis
100%
Th17 Cell
100%
Interferon
100%
Lymphocyte
100%
Experimental Autoimmune Encephalomyelitis
62%
In Vitro
50%
Central Nervous System
50%
Interleukin 17
37%
Blood Brain Barrier
25%
Interleukin 23
25%
Cytokine
12%
Endothelial Cell
12%
Primary Culture
12%
T Lymphocyte
12%
Immunocompetent Cell
12%
Pathology of Multiple Sclerosis
12%
Brain Tissue
12%
Transcription Factors
12%
Cell Migration
12%
Immunology and Microbiology
Interferon Type I
100%
Multiple Sclerosis
100%
Th17 Cell
100%
Lymphocyte
100%
Experimental Autoimmune Encephalomyelitis
62%
Central Nervous System
50%
Interleukin 17
37%
Blood Brain Barrier
25%
Interleukin 23
25%
Pathology of Multiple Sclerosis
12%
Immunocompetent Cell
12%
Brain Tissue
12%
Primary Culture
12%
Cytokine
12%
Transcription Factors
12%
T Cell
12%
Cell Migration
12%
Neuroscience
Multiple Sclerosis
100%
Interferon
100%
Lymphocyte
100%
Experimental Autoimmune Encephalomyelitis
62%
Central Nervous System
50%
In Vitro
50%
Interleukin 17
37%
In Vivo
25%
Blood Brain Barrier
25%
Interleukin 23
25%
Transcription Factors
12%
Primary Culture
12%
Pathology of Multiple Sclerosis
12%
T Cell
12%
Cell Migration
12%